Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin
Open Access
- 20 August 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cardiovascular Diabetology
- Vol. 8 (1), 46
- https://doi.org/10.1186/1475-2840-8-46
Abstract
Heparan sulfate proteoglycans (HSPGs) contain glycosaminoglycan (GAG) chains made primarily of heparan sulfate (HS). Hyperglycemia in diabetes leads to endothelial injury and nephropathy, retinopathy and atherosclerosis. Decreased HSPG may contribute to diabetic endothelial injury. Decreased tissue HS in diabetes has been reported, however, endothelial HS changes are poorly studied. To determine total GAGs, including HS, in endothelium under hyperglycemic conditions and the protective effect of insulin and heparin. Confluent primary porcine aortic endothelial cells (PAECs) were divided into control, glucose (30 mM), insulin (0.01 unit/ml) and glucose plus insulin treatment groups for 24, 48 and 72 hours. Additionally, PAECs were treated with glucose, heparin (0.5 μ g/ml) and glucose plus heparin for 72 hours. GAGs were isolated from cells and medium. GAG concentrations were determined by the carbazole assay and agarose gel electrophoresis. GAGs were significantly increased only in control and glucose plus insulin groups at 72 versus 24 hours. Glucose decreased cell GAGs and increased medium GAGs, and insulin alone decreased cell GAGs at all times compared to control. In the glucose plus insulin group, cell GAGs were less than control at 24 hours, and greater than glucose or insulin alone at 48 and 72 hours while GAGs in medium were greater than control at all times and glucose at 72 hours. Heparin increased GAGs in glucose treated cells and medium. High glucose and insulin alone reduces endothelial GAGs. In hyperglycemic conditions, heparin or insulin preserves GAGs which may protect cells from injury. Insulin is an effective diabetic therapy since it not only lowers blood glucose, but also protects endothelium.Keywords
This publication has 41 references indexed in Scilit:
- Increased expression of heparanase in overt diabetic nephropathyKidney International, 2006
- High Glucose–Induced Alterations in Subendothelial Matrix Perlecan Leads to Increased Monocyte BindingArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Effect of insulin and heparin on glucose-induced vascular damage in cell cultureKidney International, 2000
- Heparin-induced endothelial cell cytoskeletal reorganization: A potential mechanism for vascular relaxationKidney International, 1995
- Syndecan family of cell surface proteoglycans: Developmentally regulated receptors for extracellular effector moleculesCellular and Molecular Life Sciences, 1995
- Altered proteoglycan gene expression and the tumor stromaCellular and Molecular Life Sciences, 1993
- Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic ratsKidney International, 1992
- PROTEOGLYCANS: STRUCTURES AND INTERACTIONSAnnual Review of Biochemistry, 1991
- Evidence for diabetes-induced alterations in the sulfation of heparan sulfate intestinal epithelial cellsLife Sciences, 1984
- Heparan Sulfate–Rich Anionic Sites in the Human Glomerular Basement MembraneNew England Journal of Medicine, 1983